Clinical Trials Directory

Trials / Completed

CompletedNCT02675920

A Study of HCC High Risk Group Using Two Surveillance Tools

A Prospective Cohort Study to Compare Contrast Enhanced Liver CT and Ultrasonography for Hepatocellular Carcinoma Surveillance in High-risk Group of HCC: Preliminary Study

Status
Completed
Phase
Study type
Observational
Enrollment
139 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare sensitivity for hepatocellular carcinoma (HCC) of bi-annual ultrasonography and low dose computed tomography (LDCT) in patients at high risk of HCC.

Detailed description

Patients at high risk of HCC are recommended to undergo biannual surveillance using ultrasound. In this study, LDCT is performed in addition to biannual ultrasound surveillance in eligible patients to compare their sensitivity for HCC. Standard of reference would be follow-up imaging and/or gadoxetic acid-enhanced liver MRI.

Conditions

Interventions

TypeNameDescription
DRUGnon-ionic monomer iodinated CT contrast mediapatients underwent contrast-enhanced CT using aforementioned CT contrast media (non-ionic monomer iodinated CT contrast media)

Timeline

Start date
2014-11-28
Primary completion
2019-01-11
Completion
2019-10-01
First posted
2016-02-05
Last updated
2020-10-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02675920. Inclusion in this directory is not an endorsement.